These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 18670762

  • 1. Antioxidative effects of statins.
    Adam O, Laufs U.
    Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
    [Abstract] [Full Text] [Related]

  • 2. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR, Kanwar YS.
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [Abstract] [Full Text] [Related]

  • 3. Pleiotropic effects of statins.
    Liao JK, Laufs U.
    Annu Rev Pharmacol Toxicol; 2005 May; 45():89-118. PubMed ID: 15822172
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Statins and cardioprotection--more than just lipid lowering?
    Ludman A, Venugopal V, Yellon DM, Hausenloy DJ.
    Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
    [Abstract] [Full Text] [Related]

  • 6. Statins and their role in vascular protection.
    Mason JC.
    Clin Sci (Lond); 2003 Sep; 105(3):251-66. PubMed ID: 12793855
    [Abstract] [Full Text] [Related]

  • 7. The nonlipid effects of statins on endothelial function.
    Beckman JA, Creager MA.
    Trends Cardiovasc Med; 2006 Jul; 16(5):156-62. PubMed ID: 16781949
    [Abstract] [Full Text] [Related]

  • 8. The effects of statins on endothelium, inflammation and cardioprotection.
    Elrod JW, Lefer DJ.
    Drug News Perspect; 2005 May; 18(4):229-36. PubMed ID: 16034478
    [Abstract] [Full Text] [Related]

  • 9. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
    Liao JK.
    Am J Cardiol; 2005 Sep 05; 96(5A):24F-33F. PubMed ID: 16126020
    [Abstract] [Full Text] [Related]

  • 10. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
    Mason RP, Walter MF, Jacob RF.
    Circulation; 2004 Jun 01; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
    [Abstract] [Full Text] [Related]

  • 11. Statins: multiple mechanisms of action in the ischemic brain.
    Cimino M, Gelosa P, Gianella A, Nobili E, Tremoli E, Sironi L.
    Neuroscientist; 2007 Jun 01; 13(3):208-13. PubMed ID: 17519364
    [Abstract] [Full Text] [Related]

  • 12. Statins and endothelial dysfunction.
    Larose E, Ganz P.
    Semin Vasc Med; 2004 Nov 01; 4(4):333-46. PubMed ID: 15861315
    [Abstract] [Full Text] [Related]

  • 13. Potential vascular benefits of statins.
    Kinlay S.
    Am J Med; 2005 Dec 01; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [Abstract] [Full Text] [Related]

  • 14. Pleiotropic effects of statins and related pharmacological experimental approaches.
    Alegret M, Silvestre JS.
    Methods Find Exp Clin Pharmacol; 2006 Nov 01; 28(9):627-56. PubMed ID: 17200729
    [Abstract] [Full Text] [Related]

  • 15. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR, Anel RL, Zeng L, Lomasney J, Sahai A, Kanwar YS.
    Arch Immunol Ther Exp (Warsz); 2003 Nov 01; 51(3):139-48. PubMed ID: 12894868
    [Abstract] [Full Text] [Related]

  • 16. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM.
    Curr Opin Investig Drugs; 2002 Sep 01; 3(9):1312-7. PubMed ID: 12498006
    [Abstract] [Full Text] [Related]

  • 17. [Statins: possibly more than just lowering of the lipid level].
    Visseren FL, Lansberg PJ, Erkelens DW, Kastelein JJ.
    Ned Tijdschr Geneeskd; 2000 Feb 12; 144(7):316-21. PubMed ID: 10707742
    [Abstract] [Full Text] [Related]

  • 18. [The pleiotropic effects of statins].
    Wolfovitz E.
    Harefuah; 2005 Aug 12; 144(8):577-82, 597. PubMed ID: 16146158
    [Abstract] [Full Text] [Related]

  • 19. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction.
    Ito MK, Talbert RL, Tsimikas S.
    Pharmacotherapy; 2006 Jul 12; 26(7 Pt 2):85S-97S; discussion 98S-101S; quiz 106S-108S. PubMed ID: 16803418
    [Abstract] [Full Text] [Related]

  • 20. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
    Balakumar P, Kathuria S, Taneja G, Kalra S, Mahadevan N.
    J Mol Cell Cardiol; 2012 Jan 12; 52(1):83-92. PubMed ID: 21968328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.